On the prescription side, total sales increased 3.4% and 2% on a same-store basis.

“Our front-end sales are still not up to our expectations, and while the economy remains challenging, increasing customer traffic and front-end sales are our near-term priorities,” CEO Greg Wasson said in a statement. He did point to “strengthening” in Walgreen’s pharmacy performance that led to a higher market share.